Jehovah’s Witnesses Revise Long-Standing Policy on Blood Components

Jehovah’s Witnesses have announced a significant revision to their long-standing position on blood, allowing individual members to decide whether to accept or donate its four primary components—red cells, white cells, plasma and platelets.

The policy adjustment was announced by the religious organization’s Governing Body at its world headquarters in Warwick, New York. It gives the denomination’s more than nine million members greater personal responsibility when making important medical decisions involving blood components.

Under the revised guidance, each Witness may prayerfully decide whether to accept any of the four components during medical or surgical treatment. Members may also determine whether their conscience permits them to donate blood specifically for processing into components or fractions for the treatment of other people.

The announcement represents a major practical change for a religious community whose position on blood transfusion has been one of its most widely recognized and debated teachings. Previously, members were generally instructed to reject the four major components, although the acceptance of smaller blood fractions had already been treated as a matter of individual conscience.

Despite the adjustment, the prohibition against receiving whole-blood transfusions remains unchanged. Jehovah’s Witnesses are also not permitted to donate blood when it is intended to be transfused in its complete form.

The organization’s position is based on its interpretation of biblical passages instructing Christians to abstain from blood. Jehovah’s Witnesses regard blood as sacred because it represents life, which they believe is a precious gift from God.

International spokesman Paul Gillies explained that the revised guidance does not alter this fundamental belief. Rather, medical decisions involving blood components are now regarded as personal matters between individual Witnesses and Jehovah.

The change means that members may reach different conclusions without their choices automatically being treated as violations of their faith. One Witness may accept plasma or red blood cells during treatment, while another may continue to reject all blood components. Both decisions are expected to be respected as matters of personal conscience.

The new position is likely to have important consequences for healthcare professionals who treat Jehovah’s Witness patients. Doctors have frequently faced difficult ethical and clinical situations when medically recommended transfusions conflicted with a patient’s religious convictions.

Allowing members to consider red cells, white cells, plasma and platelets could make more treatment options available during major surgery, childbirth complications, severe anaemia, accidents and other medical emergencies involving substantial blood loss.

However, medical professionals will still need to consult each patient individually. The revised policy does not mean that all Jehovah’s Witnesses will accept blood components. Patients will need to state clearly which products and procedures they are willing to receive, preferably through informed discussions and properly documented advance medical directives.

The September 2026 announcement follows an earlier adjustment concerning the use of a patient’s own blood. In March, the Governing Body said members could decide whether to have their blood collected, stored and later returned to them during medical or surgical treatment.

Together, the two changes considerably expand the medical options available to members while preserving the organization’s continuing objection to whole-blood transfusions.

The development has attracted attention from religious observers, medical professionals, human-rights advocates and former members of the denomination. Critics of the previous policy have argued that restrictions on blood components exposed patients to avoidable medical risks. Supporters of religious freedom, meanwhile, emphasize the importance of respecting the right of competent adults to make healthcare decisions according to their beliefs.

The revised position shifts greater responsibility to individual Witnesses. Members must now examine the medical facts, consider relevant biblical principles and make their own conscientious decisions without expecting a single choice to apply throughout the denomination.

For healthcare institutions, the announcement highlights the importance of avoiding assumptions about what a Jehovah’s Witness patient will or will not accept. Treatment plans must be based on the expressed decision of the individual patient rather than solely on the person’s religious identity.

Although the prohibition on whole blood remains firmly in place, permitting personal choice over its main components marks a notable development in the organization’s approach to medical care. The adjustment seeks to maintain the belief that blood is sacred while giving individual members greater autonomy in decisions that may have serious consequences for their health and survival.